estropipate

Key facts

INN

estropipate

Brand

ESTROPIPATE

Route

VAGINAL

Formulation

CREAM

Originator

TEVA PHARMACEUTICAL INDUSTRIES LTD

Related patents

patent

US 12410398

Methods of human retinal progenitor cell isolation and culture

Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12397034

Pharmaceutical composition for promoting neurogenesis and method for promoting n

Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12398193

Targeted replacement of endogenous T cell receptors

Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12390427

Plasminogen activator inhibitor-1 (PAI-1) inhibitor and method of use

Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12384753

17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use there

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12371747

Methods of reducing immunogenicity against factor VIII in individuals undergoing

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12370181

Regimens of estrogen receptor antagonists

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12365875

Methods for generating skeletal muscle progenitor cells

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is estropipate?

estropipate (ESTROPIPATE), is a pharmaceutical active ingredient, associated with TEVA PHARMACEUTICAL INDUSTRIES LTD, with approved status in the US.

What is the brand name for estropipate?

ESTROPIPATE is a marketed brand name for estropipate. Check FDA Drugs@FDA for the current US label holder.